| Literature DB >> 31772591 |
Yaohan Wang1,2, Hongli Song1, Yukun Yin1, Li Feng1.
Abstract
BACKGROUND: Physical activity presents significant protection against death from cancer in the general population, so the global recommendations on physical activity for health are recommended by the WHO. While the recommendation is a guideline for general population, whether all cancer patients could get benefits from physical activity and whether the cancer patients who did not meet the requirement of the recommendation could get benefits from the physical activity, compared with the cancer patients with no physical activity, are unclear. Accordingly, we conducted a meta-analysis to identify whether the physical activity, even if low level of physical activity, could reduce the mortality of various cancer patients.Entities:
Year: 2019 PMID: 31772591 PMCID: PMC6854247 DOI: 10.1155/2019/1940903
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flow diagram of study selection.
Characteristics of the studies included in the meta-analysis.
| Study | Year | Design | Country | Study period | Cancer types | Age | Gender | Study size | Follow-up | Adjustments or match | Intervention | Comparator | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Okada et al. [ | 2017 | Cohort | Japan | 2003–2007 | Esophageal and gastric cancer | 24–95 | Male | 1604 (1053/102/338/111); death: 213 | ESCC: 4.4 years | Sex, age, year of diagnosis, BMI, smoking history, alcohol drinking history, and stage | 1-2 times/week | No habit |
|
| |||||||||||||
| 2 | Abbott et al. [ | 2018 | Case-control | USA | 2010–2015 | Ovarian cancer | 20–79 | Female | 264 (130/90/44); death: 80 | 42.7 months | Age, stage, geographic region, number of comorbid conditions, education, and income. RPA after diagnosis is additionally adjusted for prediagnosis RPA (0, >0–9, >9 MET-hours/week) | >0–9 MET-hours/week | 0 |
|
| |||||||||||||
| 3 | Bradshaw et al. [ | 2014 | Cohort | USA | 1996-1997 | Breast cancer | 25–91 | Female | 1423 (349/30/181/668); death: 420 | 5 years | Missing data: PA, chemotherapy, and tumor size, which assumes that the missing data mechanism for PA is ignorable | 0.1–9.0 MET h/week | 0 |
|
| |||||||||||||
| 4 | Kuiper et al. [ | 2012 | Cohort | USA | 1993–1998 | Colorectal cancer | 50–79 | Female | 1339 (234/166/350/312/277); death: 171 | 11.9 years | Adjusted for age at diagnosis, study arm, BMI, tumor stage, ethnicity, education, alcohol, smoking, and hormone therapy use | >0–2.9 MET-hours/week | 0 |
|
| |||||||||||||
| 5 | Hardee et al. [ | 2014 | Cohort | USA | 1987–2002 | Cancers | 18–81 (54.4) | Male | 2863 (PA: 1117/1746RE: 1612/1251); death: 121 | 7.3 years | Age, gender, and examination year, body mass index, current smoking (yes or no), heavy drinking (yes or no), hypertension (present or not), diabetes (present or not), hypercholesterolemia (yes or no), and parental history of cancer (yes or no) | RE: yes | RE: no |
| 6 | Bao et al. [ | 2015 | Cohort | China | 2002–2006 | Breast cancer | 20–75 | Female | 518 (175/343); death: 128 | 9.1 years | Age at diagnosis (continuous variable), education (<middle school, middle school, high school, >high school), marital status, Charlson comorbidity index (0, ≥1), menopausal status (yes, no), BMI at baseline (<18, 18–24.99, 25–29.99, ≥30), soy protein intake (Q1–Q4), tea consumption at baseline (yes, no), chemotherapy (yes, no), radiotherapy (yes, no), and TNM stage (I, II, III, unknown) | Yes | No |
|
| |||||||||||||
| 7 | Gunnell et al. [ | 2017 | Cohort | Australia | 2004–2011 | Cancers | 68 | Male | 1667 (439/460/384/384); death: 135 | 8.8 years | Age at survey, sex, smoking category, long-term risky drinking category, body mass index category, daily fruit and vegetable intake, survey year, self-reported diabetes, SF-8 mental health component score, SF-8 physical health component score, and previous cancer type | <150 min LTPA/week | No LTPA |
|
| |||||||||||||
| 8 | Baade et al. [ | 2011 | Cohort | Australia | 2003–2008 | Colorectal cancer | 20–70+ | Male | 1825 (748/484/593); death: 462 | 4.9 years | Not mentioned | Insufficiently active | Sedentary |
|
| |||||||||||||
| 9 | Irwin et al. [ | 2008 | Cohort | USA | 1995–2004 | Breast cancer | >18 | Female | 688 (114/297/277); death: 53 | 2.5 years | Age, race, disease stage, initial treatment, tamoxifen use, body mass index, and fruit/vegetable servings per day | >0–8.9 MET-h/wk | 0 MET-h/wk |
ESCC: esophageal cancer; GC: gastric cancer; PA: physical activity; RE: resistance exercise.
Study quality assessment (Newcastle–Ottawa scale).
| Study | Selection | Comparability | Outcome | Total no. of stars | |||||
|---|---|---|---|---|---|---|---|---|---|
| Exposed cohort | Nonexposed cohort | Ascertainment of exposure | Outcome of interest | Assessment of outcome | Length of follow-up | Adequacy of follow-up | |||
|
| |||||||||
| Okada et al. [ |
|
|
|
|
|
|
|
| 9 |
| Bradshaw et al. [ |
|
|
|
|
|
|
|
| 9 |
| Kuiper et al. [ |
|
|
|
|
|
|
| — | 8 |
| Hardee et al. [ |
|
| — |
|
|
|
|
| 8 |
| Bao et al. [ |
|
|
|
|
| — |
|
| 8 |
| Gunnell et al. [ |
|
| — |
|
|
|
|
| 8 |
| Baade et al. [ |
|
|
|
| — |
|
|
| 7 |
| Irwin et al. [ | — |
|
|
|
|
|
|
| 8 |
|
| |||||||||
|
| |||||||||
| Study | Selection | Comparability | Exposure | Total no. of stars | |||||
| Definition of cases | Representativeness of cases | Selection of controls | Definition of controls | Assessment of outcome | Method of ascertainment | Nonresponse rate | |||
|
| |||||||||
| Abbott et al. [ |
|
|
|
|
|
|
| — | 8 |
Figure 2Meta-analysis of mortality.
Figure 3Meta-analysis of low physical activity mortality.